These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26444763)

  • 21. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
    Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
    Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Dementia Severity Rating Scale predicts clinical dementia rating sum of boxes scores.
    Moelter ST; Glenn MA; Xie SX; Chittams J; Clark CM; Watson M; Arnold SE
    Alzheimer Dis Assoc Disord; 2015; 29(2):158-60. PubMed ID: 24770371
    [No Abstract]   [Full Text] [Related]  

  • 23. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohort.
    Jutten RJ; Harrison JE; Lee Meeuw Kjoe PR; Ingala S; Vreeswijk R; van Deelen RAJ; de Jong FJ; Opmeer EM; Aleman A; Ritchie CW; Scheltens P; Sikkes SAM
    Alzheimers Res Ther; 2019 May; 11(1):45. PubMed ID: 31092277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychiatric Inventory in Community-Dwelling Older Adults with Mild Cognitive Impairment and Dementia.
    Nunes PV; Schwarzer MC; Leite REP; Ferretti-Rebustini REL; Pasqualucci CA; Nitrini R; Rodriguez RD; Nascimento CF; Oliveira KC; Grinberg LT; Jacob-Filho W; Lafer B; Suemoto CK
    J Alzheimers Dis; 2019; 68(2):669-678. PubMed ID: 30856109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Latent Transition Analysis Model to Assess Change in Cognitive States over Three Occasions: Results from the Rush Memory and Aging Project.
    Zammit AR; Bennett DA; Hall CB; Lipton RB; Katz MJ; Muniz-Terrera G
    J Alzheimers Dis; 2020; 73(3):1063-1073. PubMed ID: 31884467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of a latent variable representing the dementing process.
    Royall DR; Palmer RF; O'Bryant SE;
    J Alzheimers Dis; 2012; 30(3):639-49. PubMed ID: 22451315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the Clinical Dementia Rating Scale Identify Mild Cognitive Impairment and Predict Cognitive and Functional Decline?
    Woolf C; Slavin MJ; Draper B; Thomassen F; Kochan NA; Reppermund S; Crawford JD; Trollor JN; Brodaty H; Sachdev PS
    Dement Geriatr Cogn Disord; 2016; 41(5-6):292-302. PubMed ID: 27332560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latent classes of course in Alzheimer's disease and predictors: the Cache County Dementia Progression Study.
    Leoutsakos JM; Forrester SN; Corcoran CD; Norton MC; Rabins PV; Steinberg MI; Tschanz JT; Lyketsos CG
    Int J Geriatr Psychiatry; 2015 Aug; 30(8):824-32. PubMed ID: 25363393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional reserve: The residual variance in instrumental activities of daily living not explained by brain structure, cognition, and demographics.
    Kraal AZ; Massimo L; Fletcher E; Carrión CI; Medina LD; Mungas D; Gavett BE; Farias ST
    Neuropsychology; 2021 Jan; 35(1):19-32. PubMed ID: 33393797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors and outcomes of fluctuations in the clinical dementia rating scale.
    Wilks H; Benzinger TLS; Schindler SE; Cruchaga C; Morris JC; Hassenstab J
    Alzheimers Dement; 2024 Mar; 20(3):2080-2088. PubMed ID: 38224146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial.
    Ornish D; Madison C; Kivipelto M; Kemp C; McCulloch CE; Galasko D; Artz J; Rentz D; Lin J; Norman K; Ornish A; Tranter S; DeLamarter N; Wingers N; Richling C; Kaddurah-Daouk R; Knight R; McDonald D; Patel L; Verdin E; E Tanzi R; Arnold SE
    Alzheimers Res Ther; 2024 Jun; 16(1):122. PubMed ID: 38849944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a Latent Construct for Dementia in a Population-Wide Dataset from Singapore.
    Peh CX; Abdin E; Vaingankar JA; Verma S; Chua BY; Sagayadevan V; Seow E; Zhang Y; Shahwan S; Ng LL; Prince M; Chong SA; Subramaniam M
    J Alzheimers Dis; 2017; 55(2):823-833. PubMed ID: 27802230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    Koppara A; Wolfsgruber S; Kleineidam L; Schmidtke K; Frölich L; Kurz A; Schulz S; Hampel H; Heuser I; Peters O; Reischies FM; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Pantel J; Rienhoff O; Rüther E; Henn F; Wiltfang J; Maier W; Jessen F; Kornhuber J; Wagner M
    J Alzheimers Dis; 2016; 49(2):547-60. PubMed ID: 26484902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach for estimating item sensitivity to within-person change over time: An illustration using the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog).
    Dowling NM; Bolt DM; Deng S
    Psychol Assess; 2016 Dec; 28(12):1576-1585. PubMed ID: 27046272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression.
    Polhamus DG; Dolton MJ; Rogers JA; Honigberg L; Jin JY; Quartino A
    J Prev Alzheimers Dis; 2023; 10(2):212-222. PubMed ID: 36946448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
    Göthlin M; Eckerström M; Lindwall M; Rolstad S; Eckerström C; Jonsson M; Kettunen P; Svensson J; Wallin A
    J Alzheimers Dis; 2020; 73(3):955-966. PubMed ID: 31868665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating the validity of the clinical Dementia Rating Scale: the CERAD experience. Consortium to Establish a Registry for Alzheimer's Disease.
    Fillenbaum GG; Peterson B; Morris JC
    Aging (Milano); 1996 Dec; 8(6):379-85. PubMed ID: 9061124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.